A Look At DuPont (DD) Valuation After Earnings Beat And Water Technology Updates
E. I. du Pont de Nemours and Company DD | 45.48 | -1.58% |
Why DuPont de Nemours (DD) is back on investors’ radar
DuPont de Nemours (DD) has attracted fresh attention after reporting better than expected Q4 2025 results, issuing upbeat 2026 guidance, and flagging progress across its water treatment technology portfolio.
Alongside that earnings update, the company pointed to tools like its expanded WAVE PRO modeling platform and recognition for its FilmTec Fortilife wastewater elements, which together underline how water and sustainability solutions sit within the broader DD equity story.
Despite the recent 1 month share price return of an 8.27% decline and a softer 7 day move, DuPont de Nemours still shows positive momentum with a 90 day share price return of 10.77% and a 1 year total shareholder return of 47.69%, suggesting investors are weighing upbeat earnings guidance and water technology updates against shorter term volatility.
If this focus on water treatment and materials has your attention, it could be a good moment to widen your watchlist with 23 power grid technology and infrastructure stocks as another way to spot infrastructure linked opportunities.
With DuPont trading at US$45.34 and sitting at roughly a 19% discount to the average analyst price target and an indicated 26% intrinsic discount, you have to ask: is this genuine mispricing, or is the market already accounting for that future growth?
Most Popular Narrative: 19.2% Undervalued
At $45.34, DuPont de Nemours sits below the most followed fair value estimate of $56.13, and that gap rests on a detailed earnings and cash flow story.
Improvements in supply chain agility (including local for local strategies) and mitigation of major legal liabilities (e.g., structured long term PFAS settlements) enhance free cash flow predictability and support higher future earnings through reduced volatility and risk.
Curious what kind of revenue path, margin rebuild, and future earnings multiple are baked into that $56.13 figure? The narrative leans on a specific mix of mid single digit growth, margin recovery and a premium P/E that assumes DuPont earns its place among higher quality chemicals names. The story in those assumptions is where the real debate starts.
Result: Fair Value of $56.13 (UNDERVALUED)
However, long running PFAS litigation and the risk that portfolio moves could leave a smaller, less diversified DuPont could both challenge this upbeat earnings story.
Next Steps
With both optimism around earnings and clear risks in play, it helps to look at the numbers yourself and move quickly to shape your own view. You can weigh that mix of concerns and potential upside by checking out the 3 key rewards and 2 important warning signs.
Looking for more investment ideas?
If DuPont has sharpened your interest, do not stop here, you are missing out if you skip other companies that might suit your risk tolerance and income goals.
- Target dependable cash generators by scanning companies with a solid balance sheet and fundamentals stocks screener (41 results) that can better support operations through different market conditions.
- Hunt for potential value opportunities using our 47 high quality undervalued stocks, which filters for companies where fundamentals and current pricing may not fully line up.
- Strengthen your income focus by checking out a curated set of 15 dividend fortresses that prioritise payout strength and resilience.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
